Major predictors and management of small-bowel angioectasia

• Published in: BMC gastroenterology Vol. 15; no. 1; p. 108
• Main Authors: Igawa, Atsushi, Oka, Shiro, Tanaka, Shinji, Kunihara, Sayoko, Nakano, Makoto, Aoyama, Taiki, Chayama, Kazuaki
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 25.08.2015; BioMed Central
• Subjects: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Angiodysplasia - classification; Angiodysplasia - diagnosis; Angiodysplasia - therapy; Argon Plasma Coagulation; Capsule Endoscopy; Cardiovascular Diseases - complications; Care and treatment; Complications and side effects; Double-Balloon Enteroscopy; Female; Gastroenterology; Gastrointestinal Hemorrhage - etiology; Gastrointestinal Hemorrhage - therapy; Health aspects; Hemostasis, Endoscopic; Humans; Intestinal Diseases - diagnosis; Intestinal Diseases - therapy; Intestine, Small - blood supply; Liver cirrhosis; Liver Cirrhosis - complications; Male; Middle Aged; Patient outcomes; Polyethylene Glycols - therapeutic use; Risk Factors; Sclerosing Solutions - therapeutic use; Young Adult
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/s12876-015-0337-8

Small-bowel angioectasias are frequently diagnosed with capsule endoscopy (CE) or balloon endoscopy however, major predictors have not been defined and the indications for endoscopic treatment have not been standardized. The aim of this study was to evaluate the predictors and management of small-bowel angioectasia. Among patients with obscure gastrointestinal bleeding (OGIB) who underwent both CE and double-balloon endoscopy at our institution, we enrolled 64 patients with small-bowel angioectasia (angioectasia group) and 97 patients without small-bowel angioectasia (non-angioectasia group). The angioectasia group was subdivided into patients with type 1a angioectasia (35 cases) and type 1b angioectasia (29 cases) according to the Yano-Yamamoto classification. Patient characteristics, treatment, and outcomes were evaluated. Age (P = 0.001), cardiovascular disease (P = 0.002), and liver cirrhosis (P = 0.003) were identified as significant predictors of small-bowel angioectasia. Multivariate logistic regression analysis identified cardiovascular disease (odds ratio 2.86; 95% confidence interval, 1.35-6.18) and liver cirrhosis (odds ratio 4.81; 95% confidence interval, 1.79-14.5) as independent predictors of small-bowel angioectasia. Eleven type 1a cases without oozing were treated conservatively, and 24 type 1a cases with oozing were treated with polidocanol injection (PDI). Re-bleeding occurred in two type 1a cases (6%). Seventeen type 1b cases were treated with PDI and 12 type 1b cases were treated with PDI combined with argon plasma coagulation (APC) or clipping. Re-bleeding occurred in five type 1b cases (17%) that resolved after additional endoscopic hemostasis in all cases. There was one adverse event from endoscopic treatment (1.6%). Cardiovascular disease and liver cirrhosis were significant independent major predictors of small-bowel angioectasia. Type 1a angioectasias with oozing are indicated for PDI and type 1b angioectasias are indicated for PDI with APC or clipping.